1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Smith, J.W.
Le Calvez, H.
Parra-Gessert, L.
Preece, N.E.
Jia, X.
Assa-Munt, N.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
1
90.00
90.00
90.00
1.000
1.000
1.000
C2 H4 O
44.053
ACETYL GROUP
non-polymer
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
H2 N
16.023
AMINO GROUP
non-polymer
C11 H12 N2 O2
204.225
y
TRYPTOPHAN
L-peptide linking
US
J.Biol.Chem.
JBCHA3
0071
0021-9258
277
10298
10305
10.1074/jbc.M108071200
11748219
Selection and structure of ion-selective ligands for platelet integrin alpha IIb(beta) 3.
2002
10.2210/pdb1i93/pdb
pdb_00001i93
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
1460.777
ION-SELECTIVE LIGAND D16
1
syn
polymer
no
yes
(ACE)CHWLRGDMRRC(NH2)
XCHWLRGDMRRCX
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
database_2
pdbx_nmr_software
pdbx_struct_assembly
pdbx_struct_oper_list
struct_conn
struct_site
repository
Initial release
Version format compliance
Version format compliance
Data collection
Database references
Derived calculations
1
0
2002-07-10
1
1
2008-04-27
1
2
2011-07-13
1
3
2022-02-23
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
_pdbx_nmr_software.name
_struct_conn.pdbx_leaving_atom_flag
_struct_site.pdbx_auth_asym_id
_struct_site.pdbx_auth_comp_id
_struct_site.pdbx_auth_seq_id
NMR Ensemble of Ion-Selective Ligand A1 for Platelet Integrin alphaIIb-beta3
NMR ENSEMBLE OF ION-SELECTIVE LIGAND A22 FOR PLATELET INTEGRIN ALPHAIIB-BETA3
NMR ENSEMBLE OF ION-SELECTIVE LIGAND D18 FOR PLATELET INTEGRIN ALPHAIIB-BETA3
RCSB
Y
RCSB
2001-03-17
REL
REL
The peptide was chemically synthesized: Commercial solid phase with cyclization with selective disulphide oxidation
sample
THE ENSEMBLE WAS DETERMINED USING STANDARD 2D HOMONUCLEAR NMR TECHNIQUES (CIRCA 2000)
structures with the lowest energy
200
15
NOESY & DQF-COSY
10mM PHOSPHATE/5% D2O
6.50
1
atm
278.00
K
ENSEMBLE D16 IS BASED ON A TOTAL OF 74 NOE-DERIVED DISTANCE CONSTRAINTS,
9 DIHEDRAL ANGLE RESTRAINTS, 1 COVALENT CYS-SS-CYS BOND AND 1 LRGD, I,
HYDROGEN BOND RESPECTIVELY. REFINEMENTS INCORPORATED ALPHA PROTON AND
ALPHA, BETA CARBON SHIFTS OF 11 RESIDUES.
RESTRAINED MOLECULAR DYNAMICS AND CHEMICAL SHIFT REFINEMENT.
3MG D16/ML
BRUNGER A. NILGES M. (KUSZWESKI J. CLORE G.M.)
refinement
X-PLOR
3.8.5.1 (CHEM.SHIFT.MODULE)
VARIANINC
collection
VNMR
6.1B
HARE,D. > Biosym > MSI
data analysis
Felix
2000
500
Varian
UNITYPLUS
ACE
1
n
1
ACE
1
A
CYS
2
n
2
CYS
2
A
HIS
3
n
3
HIS
3
A
TRP
4
n
4
TRP
4
A
LEU
5
n
5
LEU
5
A
ARG
6
n
6
ARG
6
A
GLY
7
n
7
GLY
7
A
ASP
8
n
8
ASP
8
A
MET
9
n
9
MET
9
A
ARG
10
n
10
ARG
10
A
ARG
11
n
11
ARG
11
A
CYS
12
n
12
CYS
12
A
CYS
12
n
13
NH2
13
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
1
A
ARG
6
0.219
SIDE CHAIN
1
A
ARG
10
0.315
SIDE CHAIN
1
A
ARG
11
0.317
SIDE CHAIN
2
A
ARG
6
0.279
SIDE CHAIN
2
A
ARG
10
0.254
SIDE CHAIN
2
A
ARG
11
0.216
SIDE CHAIN
3
A
ARG
6
0.316
SIDE CHAIN
3
A
ARG
10
0.215
SIDE CHAIN
3
A
ARG
11
0.311
SIDE CHAIN
4
A
ARG
6
0.308
SIDE CHAIN
4
A
ARG
10
0.248
SIDE CHAIN
4
A
ARG
11
0.250
SIDE CHAIN
5
A
ARG
6
0.309
SIDE CHAIN
5
A
ARG
10
0.307
SIDE CHAIN
5
A
ARG
11
0.317
SIDE CHAIN
6
A
ARG
6
0.288
SIDE CHAIN
6
A
ARG
10
0.279
SIDE CHAIN
6
A
ARG
11
0.264
SIDE CHAIN
7
A
ARG
6
0.317
SIDE CHAIN
7
A
ARG
10
0.311
SIDE CHAIN
7
A
ARG
11
0.284
SIDE CHAIN
8
A
ARG
6
0.243
SIDE CHAIN
8
A
ARG
10
0.316
SIDE CHAIN
8
A
ARG
11
0.229
SIDE CHAIN
9
A
ARG
6
0.280
SIDE CHAIN
9
A
ARG
10
0.306
SIDE CHAIN
9
A
ARG
11
0.275
SIDE CHAIN
10
A
ARG
6
0.266
SIDE CHAIN
10
A
ARG
10
0.317
SIDE CHAIN
10
A
ARG
11
0.315
SIDE CHAIN
11
A
ARG
6
0.266
SIDE CHAIN
11
A
ARG
10
0.303
SIDE CHAIN
11
A
ARG
11
0.257
SIDE CHAIN
12
A
ARG
6
0.237
SIDE CHAIN
12
A
ARG
10
0.241
SIDE CHAIN
12
A
ARG
11
0.284
SIDE CHAIN
13
A
ARG
6
0.300
SIDE CHAIN
13
A
ARG
10
0.289
SIDE CHAIN
13
A
ARG
11
0.298
SIDE CHAIN
14
A
ARG
6
0.300
SIDE CHAIN
14
A
ARG
10
0.258
SIDE CHAIN
14
A
ARG
11
0.316
SIDE CHAIN
15
A
ARG
6
0.261
SIDE CHAIN
15
A
ARG
10
0.291
SIDE CHAIN
15
A
ARG
11
0.305
SIDE CHAIN
1
A
LEU
5
-119.76
52.87
1
A
ASP
8
-85.37
-149.96
2
A
ASP
8
-90.45
-151.61
2
A
ARG
10
-86.79
40.91
3
A
ARG
6
43.35
27.31
3
A
MET
9
-87.84
40.71
3
A
ARG
10
-99.83
40.19
3
A
ARG
11
-87.29
38.66
4
A
TRP
4
-89.24
43.43
4
A
MET
9
-64.44
88.81
4
A
ARG
10
-89.50
49.25
5
A
HIS
3
-90.16
-159.24
5
A
ASP
8
-109.15
-148.88
6
A
ARG
6
36.53
44.07
6
A
MET
9
-100.12
48.62
7
A
HIS
3
-93.31
50.13
7
A
LEU
5
-116.65
-97.27
7
A
ASP
8
-81.44
-151.23
8
A
TRP
4
-91.26
45.37
8
A
LEU
5
-100.03
42.76
8
A
ASP
8
-109.60
-152.93
8
A
MET
9
-69.01
91.92
8
A
ARG
10
-86.07
48.80
9
A
ASP
8
-78.01
-156.10
9
A
MET
9
-69.54
89.12
10
A
ARG
11
64.33
-76.17
11
A
TRP
4
-102.67
47.89
11
A
ARG
6
46.03
26.93
12
A
LEU
5
-119.35
59.49
12
A
ARG
6
52.40
19.98
12
A
ASP
8
-84.28
-148.35
13
A
TRP
4
-87.80
48.83
13
A
ARG
6
59.73
14.07
13
A
ASP
8
-85.87
-148.96
14
A
HIS
3
-110.24
-156.78
15
A
LEU
5
-113.97
-101.96
15
A
ASP
8
-83.62
-155.79
15
A
ARG
10
-81.22
42.14
15
A
ARG
11
-95.38
49.67
NMR ENSEMBLE OF ION-SELECTIVE LIGAND D16 FOR PLATELET INTEGRIN ALPHAIIB-BETA3
1
N
N
disulf
2.021
A
CYS
2
A
SG
CYS
2
1_555
A
CYS
12
A
SG
CYS
12
1_555
covale
1.306
both
A
ACE
1
A
C
ACE
1
1_555
A
CYS
2
A
N
CYS
2
1_555
covale
1.304
both
A
CYS
12
A
C
CYS
12
1_555
A
NH2
13
A
N
NH2
13
1_555
CELL ADHESION
INTEGRIN, RGD, CELL ADHESION
1I93
PDB
1
1I93
1
13
1I93
1
13
1I93
A
1
1
13
BINDING SITE FOR RESIDUE ACE A 1
A
ACE
1
Software
1
BINDING SITE FOR RESIDUE NH2 A 13
A
NH2
13
Software
1
A
HIS
3
A
HIS
3
1
1_555
A
CYS
12
A
CYS
12
1
1_555
1
P 1